Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels

Purpose To evaluate the relationship between endometriosis and polymorphisms in the genes encoding tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), TRAIL receptor (DR) and osteoprotegerin (OPG) and their serum levels in Korean women.

A case–control study was conducted with 138 women with endometriosis and 214 women without endometriosis in academic medical center. TRAIL c.49G>A, c.592A>G, c.615A>G, and c.662T>C; DR4 c.626G>C and c.1322A>G; DR5 c.95C>T, c.200C>T, and c.72T>G; OPG −245T>G, c.9C>G, c.788A>C, and c.9938G>T polymorphisms were investigated and circulating levels of TRAIL and OPG were measured.

The TRAIL c.49G>A, c.615A>G, and c.662T>C; the DR4 c.626G>C; the DR5 c.72T>G; the OPG c.788A>C and c.9938G>T polymorphisms were not observed. The genotype distributions and allele frequencies of single or combined polymorphisms of TRAIL, DR4, DR5, and OPG measured in women with endometriosis were not different from those in women without endometriosis, regardless of endometriosis stage. Serum TRAIL and OPG levels were significantly lower in women with endometriosis than in women without endometriosis, but these levels did not show differences between early and advanced endometriosis.

Endometriosis is associated with circulating TRAIL and OPG levels in Korean women but not with the TRAIL, DR, and OPG polymorphisms. Similar content being viewed by others

Mathur SP (2000) Autoimmunity in endometriosis: relevance to infertility. Am J Reprod Immunol 44(2):89–95 Simpson JL, Bischoff FZ, Kamat A, Buster JE, Carson SA (2003) Genetics of endometriosis. Obstet Gynecol Clin North Am 30(1):21–40 vii Tempfer CB, Simoni M, Destenaves B, Fauser BC (2009) Functional genetic polymorphisms and female reproductive disorders: part II–endometriosis. Hum Reprod Update 15(1):97–118. doi:10.1093/humupd/dmn040 Garcia-Velasco JA, Arici A (2003) Apoptosis and the pathogenesis of endometriosis. Semin Reprod Med 21(2):165–172. doi:10.1055/s-2003-41323 Gaur U, Aggarwal BB (2003) Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66(8):1403–1408 Bersinger NA, von Roten S, Wunder DM, Raio L, Dreher E, Mueller MD (2006) PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. Am J Obstet Gynecol 195(1):103–108. doi:10.1016/j.ajog.2005.12.010 Harada M, Osuga Y, Hirata T, Hirota Y, Koga K, Yoshino O, Morimoto C, Fujiwara T, Momoeda M, Yano T, Tsutsumi O, Taketani Y (2004) Concentration of osteoprotegerin (OPG) in peritoneal fluid is increased in women with endometriosis. Hum Reprod 19(10):2188–2191. doi:10.1093/humrep/deh412 Wang SH, Cao Z, Wolf JM, Van Antwerp M, Baker JR Jr (2005) Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis. Endocrinology 146(11):4721–4726. doi:10.1210/en.2005-0627 Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M (2005) Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis 64(6):854–858. doi:10.1136/ard.2004.029058 Kim JG, Kim H, Ku SY, Kim SH, Choi YM, Moon SY (2004) Association between human alpha 2-Heremans Schmidt glycoprotein (AHSG) polymorphism and endometriosis in Korean women. Fertil Steril 82(6):1497–1500. doi:10.1016/j.fertnstert.2004.05.089 Kim SH, Choi YM, Choung SH, Jun JK, Kim JG, Moon SY (2005) Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 20(10):2904–2908. doi:10.1093/humrep/dei146 Chae SJ, Kim H, Jee BC, Suh CS, Kim SH, Kim JG (2008) Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms and their serum levels in Korean women with endometriosis. Am J Reprod Immunol 60(5):432–439 Fernandez V, Jares P, Bea S, Salaverria I, Guino E, de Sanjose S, Colomer D, Ott G, Montserrat E, Campo E (2004) Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms. Haematologica 89(11):1322–1331 Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, Rebbeck TR, Sidransky D, Gazdar AF, El-Deiry WS (2001) Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 7(6):1688–1697 Frank B, Shanmugam KS, Beckmann L, Hemminki K, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B (2006) Death receptor 4 variants and colorectal cancer risk. Cancer Epidemiol Biomark Prev 15(10):2002–2005. doi:10.1158/1055-9965.EPI-06-0053 Hazra A, Chamberlain RM, Grossman HB, Zhu Y, Spitz MR, Wu X (2003) Death receptor 4 and bladder cancer risk. Cancer Res 63(6):1157–1159 Kikuchi S, Miyagishi R, Fukazawa T, Yabe I, Miyazaki Y, Sasaki H (2005) TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol 167(1–2):170–174. doi:10.1016/j.jneuroim.2005.06.021 Yan X, Xu L, Qi J, Liang X, Ma C, Guo C, Zhang L, Sun W, Zhang J, Wei X, Gao L (2009) sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenetics 61(8):551–556. doi:10.1007/s00251-009-0389-4 American Society for Reproductive Medicine (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67(5):817–821 Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2002) Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 17(7):1245–1255. doi:10.1359/jbmr.2002.17.7.1245 Yamada Y, Ando F, Niino N, Shimokata H (2003) Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. Mol Genet Metab 80(3):344–349. doi:10.1016/S1096-7192(03)00125-2 Martinez-Ferrandis JI, Rodriguez-Lopez R, Milne RL, Gonzalez E, Cebolla E, Chirivella I, Zamora P, Arias JI, Palacios S, Cervantes A, Diez O, Benitez J, Armengod ME (2007) Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women. Cancer Biomark 3(2):89–93 Horak P, Pils D, Roessler M, Tomek S, Elandt K, Zeillinger R, Zielinski C, Krainer M (2005) Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer. Gynecol Oncol 97(2):514–518. doi:10.1016/j.ygyno.2005.01.021 Zhao HY, Liu JM, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG, Chen JL (2005) The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporos Int 16(12):1519–1524. doi:10.1007/s00198-005-1865-9 Wynne F, Drummond F, O’Sullivan K, Daly M, Shanahan F, Molloy MG, Quane KA (2002) Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. Calcif Tissue Int 71(1):26–35. doi:10.1007/s00223-001-2081-z Acknowledgments This study was supported by a National Research Foundation of Korea Grant funded by the Korean Government (2010-0015704). Conflict of Interest The authors declare that there are no conflicts of interest. Author information Authors and Affiliations Corresponding authors Additional information J. H. Kim and J. G. Kim contributed equally to this work. Rights and permissions About this article Cite this article Kim, H., Ku, SY., Suh, C.S. et al. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. Arch Gynecol Obstet 286, 147–153 (2012). https://doi.org/10.1007/s00404-012-2263-0 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-012-2263-0